Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers

Abstract excerpt

Ovarian cancer (OvCa) is a destructive malignancy due to difficulties in early detection and late advanced-stage diagnoses, leading to high morbidity and mortality rates for women. Currently, the quality treatment for OvCa includes tumor debulking surgery and intravenous platinum-based chemotherapy. However, numerous patients either succumb to the disease or undergo relapse due to drug resistance, such as to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Nanoparticle-Based Drug Delivery
• Share to Ovarian cancer diagnosis and treatment